PMS-VANCOMYCIN 125 MG — DIN 02406497
VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) : 125 MG · PHARMASCIENCE INC · CAPSULE · wholesale supply in Canada
Health Canada status: DORMANT
What is PMS-VANCOMYCIN?
PMS-VANCOMYCIN 125 MG contains VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) : 125 MG. It is listed in the Health Canada Drug Product Database under DIN 02406497, held by PHARMASCIENCE INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as dormant, status dated 31-Jul-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
What is PMS-VANCOMYCIN used for?
Treatment of staphylococcal enterocolitis and antibiotic-associated pseudomembranous colitis produced by Clostridium difficile. Not effective for other types of infection via oral route.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Vancomycin cost around the world?
Vancomycin is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 6 | 43 | USD███.██ |
| Australia | ex-manufacturer | 7 | 30 | AUD███.██ |
| Saudi Arabia | public | 19 | 24 | SAR███.██ |
| Greece | producer price (ex-factory) | 13 | 13 | EUR███.██ |
| South Africa | single exit price | 12 | 12 | ZAR███.██ |
| Romania | max producer price | 9 | 11 | RON███.██ |
| United Kingdom | hospital | 6 | 6 | GBP███.██ |
| Bahrain | retail (max) | 3 | 5 | BHD███.██ |
144 pack listings across 75 brand entries and 8 price bases, refreshed 08 Sep 2026. Ranges span every Vancomycin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Vancomycin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
3 holders have a Canadian DIN containing Vancomycin, across 8 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| JAMP PHARMA CORPORATION | 2 | 2 | JAMP VANCOMYCIN | Sourceable in Canada |
| SEARCHLIGHT PHARMA INC | 2 | 2 | VANCOCIN | Sourceable in Canada |
| PHARMASCIENCE INC | 4 | 0 | PMS-VANCOMYCIN, PMSC-VANCOMYCIN | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 125 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
| Pack configuration (monograph) | Blister packs of 20 capsules. |
| Storage | Store at room temperature (15° to 25°C). Protect from moisture. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Vancomycin |
|---|---|
| ATC code | A07AA09 |
| AHFS class | 08:12.28.16 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02406497 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2406497 |
| Brand name | PMS-VANCOMYCIN |
| Generic / active ingredient | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) : 125 MG |
| Market authorization holder | PHARMASCIENCE INC |
| Health Canada schedule | Prescription |
| ATC code | A07AA09 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A07AA |
| Current status | DORMANT |
| Status date | 31-Jul-2024 |
| Original market date | 2021-01-25 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: 125-500 mg orally every 6-8 hours for 7-10 days. Pediatrics: 40 mg/kg/day in 3-4 divided doses for 7-10 days (max 2 g/day).
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to vancomycin hydrochloride or to any ingredient in the formulation or component of the container.
Warnings and precautions
Potential for systemic absorption in inflammatory intestinal disorders. Risk of ototoxicity and nephrotoxicity. Monitor for neutropenia and development of drug-resistant bacteria.
Is Vancomycin in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by BAXTER CORPORATION, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
4 of 8 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP VANCOMYCIN | 125 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02407744 |
| JAMP VANCOMYCIN | 250 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02407752 |
| VANCOCIN | 250 MG | CAPSULE | SEARCHLIGHT PHARMA INC | MARKETED | 00788716 |
| VANCOCIN | 125 MG | CAPSULE | SEARCHLIGHT PHARMA INC | MARKETED | 00800430 |
| PMS-VANCOMYCIN | 250 MG | CAPSULE | PHARMASCIENCE INC | DORMANT | 02406500 |
| PMSC-VANCOMYCIN | 250 MG | CAPSULE | PHARMASCIENCE INC | DORMANT | 02430193 |
| PMSC-VANCOMYCIN | 125 MG | CAPSULE | PHARMASCIENCE INC | APPROVED | 02430185 |
2 · Same class — other molecules in ATC A07AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Vancomycin | JAMP VANCOMYCIN · PMS-VANCOMYCIN · PMSC-VANCOMYCIN · VANCOCIN | 8 | 4 | Yes |
| Nystatin | DOM-NYSTATIN SUSPENSION · FTP-NYSTATIN · JAMP-NYSTATIN ORAL SUSPENSION USP · MYCOSTATIN ORAL SUSPENSION 100000IU · MYCOSTATIN ORAL TAB 500000IU · NADOSTINE SUS 100000IU/ML · NADOSTINE TAB 500000UNIT · NILSTAT ORAL DPS 100000IU/ML · NILSTAT ORL TAB 500000UNIT · NILSTAT SUCROSE-FREE · NYADERM ORAL SUS 100000UNIT/ML USP · PHL-NYSTATIN SUSPENSION 100000 UNIT/ML · PMS-NYSTATIN SUSPENSION 100000 UNIT/ML · RATIO-NYSTATIN · TEVA-NYSTATIN | 15 | 3 | Yes |
| Fidaxomicin | DIFICID | 1 | 1 | Yes |
| Paromomycin | HUMATIN | 1 | 1 | Yes |
| Rifaximin | ZAXINE | 1 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PMS-VANCOMYCIN called?
The same molecule, Vancomycin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Vancomycin Juno | Latin | Australia |
| VANCOMYCIN MEDSURGE | Latin | Australia |
| Vancomycin Viatris | Latin | Australia |
| Vanco | Latin | Bahrain, Saudi Arabia |
| VANCOLON | Latin | Bahrain |
| Sterile VANCOMYCIN HCL, USP | Latin | Saudi Arabia |
| Taycan | Latin | Saudi Arabia |
| Ultavan | Latin | Saudi Arabia |
| Vancocin | Latin | Australia |
| VANCOR | Latin | Australia |
| Vanin | Latin | Saudi Arabia |
| Vancocin Cp | Latin | South Africa |
| VONDEM | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.